Cargando...
SGLT2 Inhibitors: The Star in the Treatment of Type 2 Diabetes?
Sodium-glucose cotransporter 2 (SGLT2) inhibitors are a novel class of oral hypoglycemic agents which increase urinary glucose excretion by suppressing glucose reabsorption at the proximal tubule in the kidney. SGLT2 inhibitors lower glycated hemoglobin (HbA1c) by 0.6–0.8% (6–8 mmol/mol) without inc...
Guardado en:
| Publicado en: | Diseases |
|---|---|
| Autor principal: | |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
MDPI
2020
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7349723/ https://ncbi.nlm.nih.gov/pubmed/32403420 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/diseases8020014 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|